News
4h
Discover Magazine on MSNFDA Approves Breakthrough HIV Drug, but It Could Be Hard to AccessLearn more about lenacapavir, the most effective HIV treatment and prevention drug, and how its cost could cause a setback.
Qualifying manufacturers will be able to submit some data while clinical trials are ongoing. Marty Makary is the commissioner ...
Trump’s ‘Big Beautiful Bill’ aims to drastically reduce government spending. Critics say cuts to SNAP, research funding, ...
Rachel's Ginger Beer issued a voluntary recall for its "Cucumber x Tarragon Ginger Beer" in November last year due to ...
Three people have died and more than a dozen others were hospitalized following an outbreak of listeria that has been linked ...
Little Remedies® Honey Cough Syrup was voluntarily recalled due to the presence of Bacillus cereus, which can cause two types ...
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
The U.S. Food and Drug Administration (FDA) approved a new, twice-yearly shot — the first and only of its kind — to prevent ...
The U.S. Food and Drug Administration has approved the world’s only twice-a-year shot to prevent HIV. (Scripps News) ...
The Food and Drug Administration has approved a highly effective new HIV prevention medication, known as Yeztugo. In clinical ...
Though the health and human services secretary has been avid fan of raw milk, he hasn’t pushed for changes to federal ...
ABC News contributor Dr. Alok Patel and Ian Haddock, founder of the Normal Anomaly Initiative, discuss the FDA’s decision to approve the world’s only twice-a-year injectable form of PrEP.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results